This ACNB Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday

ACNB Corporation -0.10%
Anixa Biosciences, Inc. - Common Stock -6.25%
Sanofi SA Sponsored ADR +0.34%
United States Antimony +4.70%

ACNB Corporation

ACNB

48.00

-0.10%

Anixa Biosciences, Inc. - Common Stock

ANIX

2.55

-6.25%

Sanofi SA Sponsored ADR

SNY

47.89

+0.34%

United States Antimony

UAMY

8.69

+4.70%

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Goldman Sachs analyst James Quigley initiated coverage on Sanofi (NASDAQ:SNY) with a Neutral rating and announced a price target of $65. Sanofi shares closed at $57.79 on Thursday. See how other analysts view this stock.
  • Raymond James analyst Daniel Tamayo initiated coverage on ACNB Corporation (NASDAQ:ACNB) with an Outperform rating and announced a price target of $47. ACNB shares closed at $41.25 on Thursday. See how other analysts view this stock.
  • B. Riley Securities analyst Nick Giles initiated coverage on United States Antimony Corporation (AMEX:UAMY) with a Buy rating and announced a price target of $3. United States Antimony shares closed at $1.79 on Thursday. See how other analysts view this stock.
  • Maxim Group analyst Jason McCarthy initiated coverage on Anixa Biosciences, Inc. (NASDAQ:ANIX) with a Buy rating and announced a price target of $1. Anixa Biosciences shares closed at $3.15 on Thursday. See how other analysts view this stock.

Considering buying ACNB stock? Here’s what analysts think:

Read This Next:

  • Top 2 Defensive Stocks That May Keep You Up At Night In March
This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.